TickerFacts.

Firefly Neuroscience, Inc. (AIFF): Cash & Equivalents

Annual figures by period end, from SEC filings.

Older than the company's other figures. The latest Cash & Equivalents is for the year ended 2023-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.

$682.0K
As of 2023-12-31
$9.23M
As of 2026-06-30
-28.4%
3-year compound annual growth
-19.1%
5-year compound annual growth
-11.7%
10-year compound annual growth
$4.93M2010-12-31: $1.97M2011-12-31: $1.28M2012-12-31: $2.62M2013-12-31: $2.36M2014-12-31: $2.45M2015-12-31: $2.17M2016-12-31: $1.90M2017-12-31: $2.73M2018-12-31: $1.96M2019-12-31: $1.04M2020-12-31: $1.86M2021-12-31: $4.93M2022-12-31: $731.1K2023-12-31: $682.0K$682.0K
2010-12-31 Cash & Equivalents (USD) 2023-12-31
Period endedCash & EquivalentsChange YoYSource filing
2023-12-31$682.0K-6.7%2024-03-20, Balance as of period end
2022-12-31$731.1K-85.2%2024-03-20, Balance as of period end
2021-12-31$4.93M+165.4%2023-04-17, Balance as of period end
2020-12-31$1.86M+78.8%2022-04-12, Balance as of period end
2019-12-31$1.04M-47.1%2021-03-31, Balance as of period end
2018-12-31$1.96M-28.1%2020-03-30, Balance as of period end
2017-12-31$2.73M+44.1%2019-04-01, Balance as of period end
2016-12-31$1.90M-12.6%2018-04-02, Balance as of period end
2015-12-31$2.17M-11.5%2017-03-31, Balance as of period end
2014-12-31$2.45M+3.8%2016-03-29, Balance as of period end
2013-12-31$2.36M-10.0%2015-03-20, Balance as of period end
2012-12-31$2.62M+104.8%2014-03-31, Balance as of period end
2011-12-31$1.28M-34.9%2013-03-29, Balance as of period end
2010-12-31$1.97Mn/a2012-03-30, Balance as of period end